Professor Debbie Lawlor and Professor Richard Taylor at the University of Bristol have both received awards in the Queen’s Birthday Honours which recognises the achievements of a wide range of extraordinary people across the UK.
The highly infectious variant of COVID-19 discovered in Kent, which swept across the UK last year before spreading worldwide, is between 30 and 100 per cent more deadly than previous strains, new analysis has shown.
There is an important absence of evidence regarding the effectiveness of a potentially cost-efficient intervention to prevent indoor transmission of respiratory infections, including COVID-19, warns a study by researchers at the University of Bristol.
Young people living in the Bristol area are already helping University of Bristol researchers to understand how children’s immune systems respond to COVID-19, but even more children are needed to take part, especially those from ethnic minorities.
Cleft lip and/or palate are common birth defects and affect around 15 in every 10,000 births in Europe. New research by the University of Bristol from the largest study of cleft lip and/or palate in the world, the Cleft Collective, has found epigenetics could help diagnose different types of cleft.
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
Researchers at the University of Bristol’s Centre for Academic Primary Care are looking for men who are concerned that they are, or have been, abusive in their relationships with women to take part in a new study that will help improve how we support men in changing their behaviour.
Over the past year, up and down the UK, thousands of research and innovation projects have been publicly funded to tackle the pandemic. Researchers at the universities of Bristol, Bath and Exeter, and businesses in the South West are playing a key role in how the UK is combatting COVID-19. Their work forms part of a £550 million COVID-19 rapid investment programme by UK Research and Innovation (UKRI) - the largest public funder of research and development in the UK.
A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the number of overdose deaths in England and Wales. These drugs have become drugs of abuse, according to new University of Bristol findings published in Addiction, which highlight that they are especially dangerous when used with heroin or other opioids
As the COVID-19 pandemic hit the world, academics from across the University of Bristol joined together to understand the virus and the impact of the pandemic. Today [23 March] is a year since the first UK lockdown and their research is continuing to play a key role in global efforts to overcome the disease.
